Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚น45.70 B
Marketcap
โ‚น125.77
Share price
-1.41%
Change (1 day)
128.49%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.07. In 2024 the company made an earnings per share (EPS) of -โ‚น57.50 an increase over its 2023 EPS that were of -โ‚น71.87.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.48%
2024-โ‚น57.50-20%
2023-โ‚น71.8731.15%
2022-โ‚น54.80-0%
2021-โ‚น54.8010.91%
2020-โ‚น49.41-145.08%
2019โ‚น109.60-206.09%
2018-โ‚น103.31-5.74%
2017-โ‚น109.60-10.95%
2016-โ‚น123.082640%
2015-โ‚น4.49-96.34%
2014-โ‚น122.59-2.53%
2013-โ‚น125.77-9.09%
2012-โ‚น138.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,891 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,902-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น533.63 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น244.36-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,558-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น48.51 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น401.57-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น214.71-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.38 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA